Grape King Bio Ltd. | Mutual Funds
Mutual Funds that own Grape King Bio Ltd.
Fidelity Low Priced Stock Fund
1,748,000
1.29%
0
0.04%
04/30/2018
Swedbank Robur Global Emerging Markets
1,661,000
1.23%
0
1.23%
07/31/2018
Vanguard Emerging Markets Stock Index Fund
1,614,039
1.19%
0
0.01%
07/31/2018
Vanguard Total International Stock Index Fund
1,538,000
1.12%
0
0%
07/31/2018
Government Pension Fund - Global (The)
1,493,999
1.1%
535,961
0%
12/31/2017
British Columbia Inv Management Corp.
1,153,000
0.85%
132,000
0.01%
03/31/2017
iShares Core MSCI Emerging Markets ETF
1,038,000
0.77%
0
0.02%
09/05/2018
DFA Emerging Markets Core Equity Portfolio
1,004,000
0.74%
41,000
0.03%
04/30/2018
DFA Emerging Markets Small Cap Series
755,000
0.56%
0
0.07%
01/31/2018
Allianz Global Investors Taiwan Technology Fund
708,446
0.52%
108,447
3.25%
03/31/2018
| Address |
No. 402, Section 2 Jinling Road
Taoyuan 324
Taiwan
|
|
Employees
|
- |
| Website |
http://www.grapeking.com.tw |
| Updated |
07/08/2019 |
| Grape King Bio Ltd. engages in the manufacture and sale of health food products. It focuses on the mushroom mycelium and probiotics. Its business activities include preparation of pharmaceutical products, medicines, and raw materials; as well as the manufacture and trade of medical equipment. |
